Sales by business segments/mainly products

Business Segment

(Millions of yen)

2020/3 2021/3 2022/3 2023/3 2024/3
New ethical drugs, etc. (Japan) 77,535 69,735 69,725 74,770 82,581
New ethical drugs (Overseas) 1,490 996 1,033 308 386
Generic drugs 30,957 32,172 34,775 38,190 36,564
Net sales 109,983 102,904 105,534 113,270 119,532

“Accounting Standards for Revenue Recognition” (ASBJ Statement No.29, Mar 31, 2020) etc. have been applied from the beginning of March 2022.

Main Products

Beova

A sales graph of "Beova" will be displayed.
Photo: Beova
Therapeutic agent for overactive bladder
Beova Tablets 50mg

Lasvic

A sales graph of "Lasvic" will be displayed.
Photo: Lasvic
New Quinolone synthetic antibacterial agent
Lasvic Tablets 75mg
Lasvic Intravenous Drip Infusion Kit 150mg

Lyfnua

A sales graph of "Lyfnua" will be displayed.
Photo: Lyfnua
Cough treatment
Lyfnua tablets 45mg

Desalex

A sales graph of "Desalex" will be displayed.
Photo: Desalex
Antiallergic Agent
Desalex Tablets 5mg

Flutiform

A sales graph of "Flutiform" will be displayed.
Photo: Flutiform
Combination drug for asthma treatment
Flutiform 50 Aerosol - 56 inhalations / 120 inhalations
Flutiform 125 Aerosol - 56 inhalations / 120 inhalations

Pentasa

A sales graph of "Pentasa" will be displayed.
Photo: Pentasa
Ulcerative Colitis / Crohn's Disease Remedy
PENTASA Tablets 250mg
PENTASA Tablets 500mg
PENTASA Granules 94%
Ulcerative Colitis Remedy
PENTASA Enema 1g
PENTASA Suppositories 1g

Kipres

A sales graph of "Kipres" will be displayed.
Photo: Kipres
Leukotriene receptor antagonist
Anti-Bronchial asthma and allergic rhinitis drug
KIPRES Tablets 5mg
KIPRES Tablets 10mg
KIPRES OD Tablets 10mg
Leukotriene receptor antagonist
Anti-Bronchial asthma drug
KIPRES Fine Granules 4mg
KIPRES Chewable Tablets 5mg

Mucodyne

A sales graph of "Mucodyne" will be displayed.
Photo: Mucodyne
Mucoregulating drug
MUCODYNE Tablets 250mg
MUCODYNE Tablets 500mg
MUCODYNE Syrup 5%
MUCODYNE DS 50%

Uritos

A sales graph of "Uritos" will be displayed.
Photo: Uritos
Therapeutic agent for overactive bladder
URITOS Tablets 0.1mg
URITOS OD Tablets 0.1mg

Montelukast “KM”

A sales graph of "Montelukast “KM”" will be displayed.
Photo: Montelukast “KM”
Treatment for Bronchial asthma, allergic rhinitis
MONTELUKAST Tablets 5mg “KM”
MONTELUKAST Tablets 10mg “KM”

Mometasone “KYORIN”

A sales graph of "Mometasone “KYORIN”" will be displayed.
Photo: Mometasone “KYORIN”
Allergic Rhinitis Therapeutic Agent
MOMETASONE NASAL 50μg “KYORIN”56sprays
MOMETASONE NASAL 50μg “KYORIN”112sprays

Imidafenacin “KYORIN”

A sales graph of "Imidafenacin “KYORIN”" will be displayed.
Photo: Imidafenacin “KYORIN”
Therapeutic agent for overactive bladder
IMIDAFENACIN Tablets 0.1mg “KYORIN”
IMIDAFENACIN OD Tablets 0.1mg “KYORIN”

(Billions of yen)

2020/3 2021/3 2022/3 2023/3 2024/3
Beova 4.3 7.3 8.6 12.9 18.1
Lasvic 1.1 0.9 1.8 2.5 4.9
Lyfnua - - - 0.2 0.8
Desalex 2.6 5.7 7.1 8.5 8.9
Flutiform 14.6 13.3 12.6 12.0 12.9
Pentasa 13.3 12.8 14.0 12.8 12.3
Kipres 11.8 8.3 8.4 6.6 7.0
Mucodyne 5.8 3.3 3.5 3.5 4.2
Uritos 5.8 2.3 1.3 0.7 0.5
Montelukast “KM” 11.5 10.8 12.2 13.3 12.3
Mometasone “KYORIN” 2.8 3.8 3.6 4.7 4.5
Imidafenacin “KYORIN” - 0.7 0.8 0.7 0.6